创金合信全球医药生物股票发起(QDII)A(018155)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
19,116.35 |
43,199.92 |
47,673.18 |
| 存出保证金 |
14,411.47 |
87,151.93 |
13,706.88 |
| 交易性金融资产 |
11,707,017.51 |
10,443,164.83 |
10,802,041.09 |
| 其中：股票投资 |
11,707,017.51 |
10,443,164.83 |
10,802,041.09 |
| 债券投资 |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
1,220,867.72 |
- |
- |
| 应收利息 |
- |
- |
- |
| 应收股利 |
- |
271.72 |
2,271.95 |
| 应收申购款 |
118,794.30 |
227,656.24 |
14,477.86 |
| 其他资产 |
- |
- |
- |
| 资产总计 |
14,392,620.06 |
12,774,490.75 |
13,050,321.93 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
231,283.38 |
67,468.75 |
344,992.05 |
| 应付赎回款 |
274,026.73 |
40,262.56 |
107,383.73 |
| 应付管理人报酬 |
13,742.13 |
15,933.00 |
15,599.24 |
| 应付托管费 |
2,290.37 |
2,655.50 |
2,599.87 |
| 应付销售服务费 |
2,921.05 |
2,564.50 |
2,618.11 |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
- |
- |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
21,441.54 |
27,296.98 |
33,997.74 |
| 负债合计 |
545,705.20 |
156,181.29 |
507,190.74 |
| 所有者权益 |
| 实收基金 |
12,731,078.35 |
13,894,416.59 |
12,509,110.92 |
| 未分配利润 |
1,115,836.51 |
-1,276,107.13 |
34,020.27 |
| 所有者权益合计 |
13,846,914.86 |
12,618,309.46 |
12,543,131.19 |
| 负债及所有者权益总计 |
14,392,620.06 |
12,774,490.75 |
13,050,321.93 |
微信公众号
证券之星APP
基本资料
